Introduction
Table of Contents
Aspergillus antibody testing, specifically IgG and IgE, helps diagnose aspergillosis, particularly chronic pulmonary aspergillosis and allergic bronchopulmonary aspergillosis, by detecting antibodies in the blood against the fungus.
Types of Tests
- Types of Tests:
- IgG Antibody Tests: These tests are particularly useful for diagnosing chronic pulmonary aspergillosis (CPA) and monitoring treatment response.
- IgE Antibody Tests: These tests help detect Aspergillus sensitization and diagnose allergic bronchopulmonary aspergillosis (ABPA).
- Skin Prick Test: The skin prick test against A. fumigatus is more sensitive than blood testing for detecting Aspergillus sensitization.
- Immunodiffusion Tests: These tests detect precipitating antibodies to Aspergillus species.
- Galactomannan Antigen Test: This test detects galactomannan, a component of the fungal cell wall, in blood or bronchoalveolar lavage fluid and is considered the gold standard for diagnosing invasive pulmonary aspergillosis (IPA).
Clinical Significance
- CPA and ABPA: Antibody testing is central to the diagnosis of these conditions.
- Monitoring Treatment: Antibody levels can be used to monitor treatment response in CPA and Aspergillus rhinosinusitis.
- Invasive Pulmonary Aspergillosis (IPA): While antibody tests have limited value in diagnosing IPA, they can be used in non-neutropenic patients.
Interpreting Results
- Positive Results: Elevated levels of Aspergillus-specific IgG or IgE antibodies may indicate an infection or sensitization.
- Negative Results: Negative results do not necessarily exclude aspergillosis, especially in the context of IPA.
- Intermediate Results: Results between the positive and negative thresholds may indicate a need for further testing or monitoring.
- Other Considerations
- Multiple Aspergillus Species: Some antibody tests can detect antibodies against multiple Aspergillus species, including A. fumigatus, A. flavus, and A. niger.
- Cross-reactivity: Preliminary evidence suggests that patients with infections caused by other Aspergillus species may produce cross-reacting antibodies.
- Immunocompetent Patients: Antibody tests are indicated for the diagnosis of ABPA, aspergilloma, paranasal sinus aspergillosis, and other forms of aspergillosis in immunocompetent patients.
Keynotes
- Aspergillus-antibody testing detects immune response markers.
- Additionally, it measures IgG, IgM, and IgE antibodies.
- Researchers employ ELISA for quantitative analysis.
- Furthermore, the test differentiates between colonization and infection.
- Clinicians use these assays to diagnose aspergillosis.
- Moreover, testing assists in monitoring treatment efficacy.
- Laboratories prepare serum samples for analysis.
- Also, the assays follow strict quality control protocols.
- In addition, immunoblot methods provide confirmatory results.
- Finally, rapid tests improve timely diagnosis.
- Therefore, antibody testing guides patient management.
Further Readings
- https://miravistalabs.com/medical-fungal-infection-testing/antibody-detection/aspergillus-antibody-immunodiffusion/
- https://www.sciencedirect.com/science/article/pii/S1198743X23000551
- https://pubmed.ncbi.nlm.nih.gov/25980000/
- https://www.labcorp.com/tests/606846/aspergillus-precipitating-antibodies-igg
- https://www.leedsth.nhs.uk/services/pathology/tests/aspergillus-antibodies/
- https://www.ganeshdiagnostic.com/aspergil-anti-igg-serum-test
- https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(23)00055-1/pdf
- https://www.aspergillus.org.uk/diagnosis/antibody-testing/
- https://mlabs.umich.edu/tests/aspergillus-antibodies-immunodiffusion
- https://www.leedsth.nhs.uk/services/pathology/tests/aspergillus-antigen
- https://pubmed.ncbi.nlm.nih.gov/24671798/